Ergomed plc Ergomed to Present at Jefferies Conference (0930A)
May 28 2021 - 1:00AM
UK Regulatory
TIDMERGO
RNS Number : 0930A
Ergomed plc
28 May 2021
PRESS RELEASE
Ergomed to Present at Jefferies Virtual 2021 Healthcare
Conference
Guildford, UK - 28 May 2021: Ergomed plc (LSE: ERGO) ('Ergomed'
or the 'Company'), a company focused on providing specialised
services to the pharmaceutical industry, today announces that
Richard Barfield, Chief Financial Officer of Ergomed, will present
at the Jefferies Virtual Healthcare Conference at 1pm BST on 2 June
2021.
A live webcast of the presentation will be available on
Ergomed's website, here:
https://www.ergomedplc.com/investor-relations/reports-and-presentations/
ENDS
Enquiries:
Ergomed plc Tel: +44 (0) 1483 402
975
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited Tel: +44 (0) 20 7260 1000
Freddie Barnfield / Matthew O'Dowd (Nominated
Adviser)
James Black (Broker)
Consilium Strategic Communications Tel: +44 (0) 20 3709 5700
Chris Gardner / Matthew Neal ergomed@consilium-comms.com
Angela Gray / Lucy Featherstone
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing
services business includes an industry-leading suite of specialist
pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand and a full range of high-quality clinical
research and trial management services under the Ergomed brand
(CRO). For further information, visit: http://ergomedplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCSEWFIWEFSEEI
(END) Dow Jones Newswires
May 28, 2021 02:00 ET (06:00 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2023 to Apr 2024